Direct radioimmunoassays of renin and renin substrate during converting-enzyme inhibition.
In 10 severely hypertensive patients, on a low sodium diet, converting enzyme inhibition increased plasma renin activity and decreased plasma renin substrate. The use of direct radioimmunoassays for both the enzyme and its substrate showed that the number of immunoreactive renin molecules increased from 11.3 +/- 4.9 to 31.7 +/- 25.3 pmol 1(-1) whereas the number of immunoreactive renin substrate molecules decreased from 1.04 +/- 0.35 to 0.74 +/- 0.16 mumol 1(-1). The direct radioimmunoassay for angiotensinogen gave higher values than the direct enzymatic assay, and during converting enzyme inhibition, the difference between both methods increased in proportion to the rise in circulating renin. It is concluded that the difference between the renin substrate radioimmunoassay, which measures angiotensinogen and des-angio I-angiotensinogen, and the renin substrate enzymatic assay which only measures "active" substrate, is an index of the increased consumption of renin substrate, in a situation where the fall in angiotensin II enhances renin release and decreases renin substrate release.
D000806:Angiotensin-Converting Enzyme Inhibitors; D000808:Angiotensinogen / Q000097:blood*; D000809:Angiotensins / Q000097:blood*; D004789:Enzyme Activation; D004792:Enzyme Precursors / Q000097:blood; D006801:Humans; D006973:Hypertension / Q000097:blood*; D011863:Radioimmunoassay / Q000379:methods; D012083:Renin / Q000097:blood*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000809:Angiotensins; D004792:Enzyme Precursors; D000808:Angiotensinogen; D012083:Renin